News
AstraZeneca sets lofty target of $80bn in revenues by 2030
AstraZeneca easily delivered on chief executive Pascal Soriot’s …
19727 items found
News
Internal budgets ‘holding back pharma’s digital evolution’
Digital investment in the pharma sector is continuing at a steady …
Digital
The commercialisation of quantum science in pharma
In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S …
News
FDA competition seeks digital endpoints for Parkinson’s
The FDA is asking digital health technology developers to come up …
Patients
Closing the bipolar diagnosis gap for Black Americans
April was both National Minority Health Month and Counselling …
News
EU rules PTC’s Duchenne drug can stay on the market
Going against the advice of its own advisors, the European Commission …
News
Novavax investor withdraws proxy fight after Sanofi deal
Shah Capital Management has withdrawn a proxy campaign against the …
Digital
Unlocking biotech insights: Top 10 podcasts you need to listen to
In the fast-paced world of biotechnology, staying informed and …
News
Biotechs Rapport and Telix throw their hats into IPO ring
Australian radiopharma developer Telix Pharma and US neuroscience …
Digital
Sponsored
PDURS explained: The FDA’s new framework for adding software to drug labels
The US FDA has recently proposed a new draft framework that enables …
News
AstraZeneca unveils plan for $1.5bn ADC plant in Singapore
AstraZeneca is backing up its considerable investment in …
News
ATS: Vicore, Endeavor therapies show promise in IPF
Two experimental therapies from Vicore Pharma and Endeavor …
News
Intellia trumpets CRISPR drug data, but shares fall
Intellia has reported results from a phase 2 trial of its gene-editing drug for hereditary angioedema (HAE) that it says build the case for the drug as a phase 3 trial gets underway – but i
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
LSX 2024 - Dr Tadaaki Taniguchi
At LSX in Boston last month, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some r
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Patients
Partner Content
How walking in a patient's shoes adds value to your patient ...
Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
